MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
At Google I/O 2026, Alphabet unveiled a suite of new AI models and features, including Gemini 3.5 Flash, Omni, and Antigravity 2.0, as it looks to sharpen its competitive edge.
Atalaya Mining (LON:ATYM) reported first-quarter 2026 results that were held back by heavy rainfall in Spain, but management said stronger metal prices, silver credits and unusually favorable concentrate market conditions helped offset the production shortfall.
Chief Executive Officer Alberto Lavan
Karyopharm Therapeutics (NASDAQ:KPTI) executives said the company expects to provide a fuller presentation of its Phase 3 SENTRY trial data for selinexor in myelofibrosis at the upcoming ASCO conference, while also outlining expected regulatory engagement and other development priorities during a re
KLA (NASDAQ:KLAC) is seeing stronger momentum across semiconductor equipment markets than it expected earlier in the year, with demand improving across leading-edge logic, memory and advanced packaging, Chief Financial Officer Bren Higgins said at J.P. Morgan’s 54th annual Global Technology, Media a
J.B. Hunt Transport Services (NASDAQ:JBHT) executives said intermodal demand remains “pretty good,” with volume gains driven more by company-specific share wins than by a broadly robust freight market, during a Wolfe Research conference session moderated by Scott Group, managing director and senior
Disc Medicine (NASDAQ:IRON) Chief Executive Officer John Quisel said patient demand for the company’s bitopertin program in erythropoietic protoporphyria, or EPP, remains strong after the company enrolled 183 patients in the APOLLO confirmatory study, above its original target of 150.
Speaking at a
JOYY (NASDAQ:YY) reported its strongest year-over-year revenue growth in recent years in the first quarter of 2026, as its social entertainment business returned to growth and newer businesses in advertising technology and commerce continued to scale.
The company said total net revenue rose 12.4% y
Opus Genetics (NASDAQ:IRD) is advancing a portfolio of gene therapies for inherited retinal diseases, with two programs already in the clinic and three more expected to enter clinical testing within the next 12 months, President Dr. Ben Yerxa said during a fireside chat at RBC Capital Markets’ 2026
PPDAI Group (NYSE:FINV), referred to on the call as FinVolution Group, reported a steady first quarter of 2026 as management highlighted improving credit trends in China, continued overseas growth and a new reporting structure designed to give investors more visibility into its international operati
Ionis Pharmaceuticals (NASDAQ:IONS) highlighted a busy slate of regulatory decisions, clinical readouts and partnered programs during a presentation at RBC Capital Markets’ Global Healthcare Conference, with Chief Development Officer Holly Kordasiewicz saying the company is moving from recent launch
Intel (NASDAQ:INTC) Chief Executive Officer Lip-Bu Tan said the company has made progress on strengthening its balance sheet, improving execution and rebuilding customer trust, while acknowledging that its foundry ambitions remain a long-term effort.
Speaking with J.P. Morgan semiconductor analyst
Intapp (NASDAQ:INTA) executives said artificial intelligence is emerging as a demand driver for the company’s professional-services software platform, particularly as large law firms, accounting firms, consulting firms, investment banks and private capital firms look for compliant ways to automate w
Inovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young LLP as the company’s independent registered public accounting firm for the year ending Dec. 31,
Incyte (NASDAQ:INCY) Chief Medical Officer Steven Stein outlined the company’s development priorities across hematology, oncology and immunology, with a particular focus on its mutant CALR antibody 989, during a company news event.
Stein said myeloproliferative neoplasms remain “front and center” f
Microsoft stock may be nearing the end of its valuation discount as several catalysts and bullish technical signals create new upside potential for MSFT shares.
LexinFintech (NASDAQ:LX) reported higher first-quarter loan volume and revenue as management said growth in its diversified ecosystem businesses helped offset pressure in online consumer finance amid macroeconomic and industry challenges.
On the company’s first-quarter 2026 earnings call, Chairman
IDEAYA Biosciences (NASDAQ:IDYA) Chief Executive Yujiro Hata said the precision oncology company is preparing for a busy 2026, led by regulatory and clinical milestones for darovasertib in metastatic uveal melanoma and multiple data readouts across its pipeline.
Speaking at a Stifel-hosted event, H
InterDigital (NASDAQ:IDCC) executives outlined the company’s licensing model, growth targets and patent-enforcement strategy during an appearance at the J.P. Morgan TMC conference, emphasizing the company’s role in wireless, video compression and artificial intelligence research.
Liren Chen, InterD
IAC (NASDAQ:IAC) is continuing its transformation from a holding company into People Incorporated, with executives describing the shift as a continuation of a strategy outlined earlier this year that includes asset sales, cost reductions and a sharper focus on People Inc. and MGM Resorts Internation
Horizon Quantum Computing Pte. (NASDAQ:HQ) is positioning itself as a software-focused company in the quantum computing sector, aiming to build a hardware-agnostic development environment that can help developers write code for multiple types of quantum computers, Chairman and CEO Dr. Joseph Fitzsim
Honeywell International (NASDAQ:HON) is on track to complete its planned separation on June 29, the first day of the third quarter, Chief Financial Officer and Senior Vice President Mike Stepniak said at an investor conference.
Stepniak said the company is in the “final stages” of separating and de
GSI Technology (NASDAQ:GSIT) is positioning its associative processing unit, or APU, technology for artificial intelligence workloads at the edge rather than in data centers, Vice President of Sales and Investor Relations Didier Lasserre said during a company presentation.
Lasserre, who said he has
Gilead Sciences (NASDAQ:GILD) Chief Medical Officer Dietmar Berger outlined several upcoming clinical and regulatory priorities across oncology, inflammation and HIV during a discussion with RBC Capital Markets senior biotech analyst Brian Abrahams.
Berger said Gilead is focused on advancing Trodel
GlobalFoundries (NASDAQ:GFS) Chief Financial Officer Sam Franklin said the company is positioning itself around data center demand, physical AI, silicon photonics, supply-chain diversification and custom silicon as it looks to expand revenue and margins over the next several years.
Speaking with JP
Palantir and Dell unveiled a secure AI operating system powered by NVIDIA infrastructure, targeting defense, healthcare, and regulated enterprise customers
Gaia (NASDAQ:GAIA) Chief Financial Officer Ned Preston told investors at the LD Micro Invitational that the company is leaning on its niche streaming model, expanding artificial intelligence tools and new community features to drive higher average revenue and retention while maintaining a focus on f
Fortinet (NASDAQ:FTNT) executives said demand for AI-related data center security, operational technology protection and sovereign SASE offerings is contributing to a stronger pipeline, while the company continues to see product growth supported by firewall demand.
Speaking at a J.P. Morgan-hosted
JFrog (NASDAQ:FROG) executives said the company’s cloud business is benefiting from rising software usage tied in part to artificial intelligence experimentation, but management emphasized that it is maintaining a conservative forecasting approach because customer usage patterns remain uncertain.
S
Fermi (NASDAQ:FRMI) co-founder and largest shareholder Toby Neugebauer said he is calling for a special shareholder meeting to elect a new board majority, arguing that the company should evaluate strategic alternatives alongside its current tenant strategy for Project Matador.
On a shareholder upda
Flywire (NASDAQ:FLYW) CEO Mike Massaro said the payments company is seeing benefits from a strategic review that focused on streamlining operations, improving data and systems, and reinvesting in priority areas.
Speaking in a fireside chat with Tien-Tsin Huang, Payments and IT Services Analyst at J
Flexsteel Industries (NASDAQ:FLXS) executives outlined the furniture manufacturer’s growth strategy, margin outlook and capital allocation priorities during a company presentation, emphasizing recent share gains despite a weak industry backdrop.
President and CEO Derek Schmidt said the company has
Flex (NASDAQ:FLEX) executives used a J.P. Morgan fireside chat to outline the rationale for the company’s latest planned spin-off, describe the growth expectations for the business being separated and frame the remaining Flex as a large, diversified manufacturing and services platform.
Revathi Adva
Fiserv (NASDAQ:FISV) Chief Executive Officer Mike Lyons said the payments and financial technology company is focused on returning to a “constant compounder” profile by sharpening its business mix, improving execution and investing around two major markets: banking and commerce.
Speaking with J.P.
Fennec Pharmaceuticals (NASDAQ:FENC) executives outlined the company’s commercial strategy for PEDMARK, its sodium thiosulfate product used to prevent cisplatin-related hearing loss, during a fireside chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference.
Ram Selvaraju, managing dir
Kiniksa Pharmaceuticals is gaining momentum after strong ARCALYST sales growth, raised revenue guidance, and optimism surrounding its next-generation pipeline
Expedia Group (NASDAQ:EXPE) used a company event marking 30 years of Expedia to outline new partnerships, artificial intelligence initiatives and partner tools aimed at increasing traveler demand and simplifying travel operations.
CEO Ariane Gorin said the company’s purpose remains “to help travele
Stocks were up sharply to end the week as NVIDIA’s forward guidance showed tangible demand to support AI infrastructure and overshadowed mixed retail reports
Exelixis (NASDAQ:EXEL) remains focused on expanding its CABO franchise while preparing for potential launches and data readouts tied to zanzalintinib, Andrew Peters, the company’s senior vice president of strategy, said during a session hosted by RBC Capital Markets.
Peters said Exelixis’ guidance
Enlight Renewable Energy (NASDAQ:ENLT) used its 2026 Investor Day to outline its long-term growth strategy, emphasizing renewable power demand, expansion in the United States and Europe, operational execution and a new push into data center development.
Itay Banayan, Enlight’s chief corporate devel
Euronet Worldwide (NASDAQ:EEFT) used its 2026 Investor Day to reposition its business as a global payments platform built around shared technology, cross-segment distribution and digital growth initiatives, while management laid out a multi-year outlook calling for continued earnings growth and marg
Definium Therapeutics (NASDAQ:DFTX) Chief Financial Officer Brandi Roberts said the company is preparing for several key clinical and regulatory milestones for DT-120, including anticipated Phase III data in major depressive disorder later this quarter and ongoing Phase III work in generalized anxie
Datadog (NASDAQ:DDOG) CEO and co-founder Olivier Pomel said the company is benefiting from both ongoing cloud migration and the rapid expansion of artificial intelligence workloads, describing the observability and security provider as still early in a long-running market cycle.
Speaking at a compa
Cytokinetics (NASDAQ:CYTK) executives said the commercial launch of MYKORZO is tracking ahead of internal expectations, while also highlighting positive physician feedback on the drug’s label, REMS program and recent clinical data in hypertrophic cardiomyopathy during a discussion hosted by RBC Capi
Crexendo (NASDAQ:CXDO) President and Chief Operating Officer Doug Gaylor told investors at an LD Micro presentation that the cloud communications company is on track for sharply higher revenue and is continuing to grow profitably while pursuing acquisitions among its software licensee base.
Gaylor
Cavco Industries (NASDAQ:CVCO) reported higher fourth-quarter revenue and profit compared with the prior year, while management said orders strengthened late in the period and backlogs improved heading into the new fiscal year.
On the company’s fiscal fourth-quarter earnings call, President and CEO
Global Ship Lease (NYSE:GSL) executives said the container ship lessor entered 2026 with full charter coverage for the year, a strengthened balance sheet and more than $2 billion in contracted revenue, while warning that escalating geopolitical disruptions are reshaping global trade routes and vesse
Bicara Therapeutics (NASDAQ:BCAX) said new data to be presented at the 2026 American Society of Clinical Oncology annual meeting support the clinical profile of ficerafusp alfa, also referred to by the company as Ficara, in first-line recurrent or metastatic HPV-negative head and neck cancer.
On an
Flowers Foods (NYSE:FLO) said it delivered first-quarter bottom-line results ahead of expectations despite softer sales trends and continued pressure in the traditional bread category, as management pointed to brand investment, cost controls and balance sheet priorities as key themes for the rest of
Frontline (NYSE:FRO) reported what Chief Executive Officer Lars Barstad called the company’s most profitable quarter since 2004, as tanker markets were reshaped by the effective closure of the Strait of Hormuz and shifting global oil trade patterns.
Speaking on the company’s first-quarter 2026 earn
Imperial Petroleum (NASDAQ:IMPP) reported sharply higher first-quarter 2026 results, with management saying the company benefited from a larger fleet and a surge in tanker rates tied to geopolitical disruptions in the Middle East.
Chief Executive Officer Harry Vafias said the quarter marked the com
CAE (NYSE:CAE) reported higher fourth-quarter and full-year revenue for fiscal 2026, but management said weaker civil aviation training conditions, disruption tied to the Middle East conflict and transformation-related costs weighed on profitability and will continue to affect the company’s near-ter
ProSiebenSat.1 Media (ETR:PSM) used its annual general meeting to outline a sharper focus on entertainment, tighter financial discipline and continued cost reductions following a year marked by weak advertising markets, portfolio disposals and a change in control after MFE became majority shareholde
Booz Allen Hamilton (NYSE:BAH) executives said the government technology contractor exited what Chief Executive Horacio Rozanski called its “most challenging year” as a public company with stronger profitability than expected, even as revenue declined because of weakness in its civil business.
On t
BJ's Wholesale Club (NYSE:BJ) reported a solid start to fiscal 2026, with management pointing to membership gains, higher fuel volumes, digital adoption and new club openings as key drivers of first-quarter performance.
Chairman and Chief Executive Officer Bob Eddy said the retailer’s results were
Deere stock fell after earnings despite a double beat as weakness in agriculture offset strong AI-driven construction demand tied to data center growth
So-Young International (NASDAQ:SY) reported sharply higher first-quarter 2026 revenue, driven by rapid growth in its branded aesthetic center business, while management said the company is continuing to expand its clinic footprint and invest in standardized medical delivery.
Total revenue rose 45.6
Contineum Therapeutics (NASDAQ:CTNM) President and Chief Executive Officer Carmine Stengone said the company remains focused on advancing PIPE-791 in idiopathic pulmonary fibrosis, while recent exploratory pain data may point to additional clinical opportunities for the LPA1 receptor antagonist.
Sp
Intuit is aggressively shifting its corporate strategy toward artificial intelligence to streamline operations and unlock unprecedented margin expansion.
